Wow what a fantastic deal. BOT have acquired a phase 3 complete drug with a massive market, and have done so with a low upfront cost and without diluting shareholders.
This really is best case scenario for this announcement.
BOT leveraging the excellent management team they have to pivot into new areas while waiting on the core portfolio to progress through studies. The BOT team know how to get drugs through the FDA process, so makes sense we buy a derisked product after phase 3 and just complete an easy but massive value add by getting it through the FDA.
All faith restored in this company.
- Forums
- ASX - By Stock
- BOT
- Ann: Dermatology Asset Acquired to Accelerate Path to Revenue
Ann: Dermatology Asset Acquired to Accelerate Path to Revenue, page-25
-
- There are more pages in this discussion • 127 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BOT (ASX) to my watchlist
(20min delay)
|
|||||
Last
36.0¢ |
Change
-0.010(2.70%) |
Mkt cap ! $654.2M |
Open | High | Low | Value | Volume |
37.0¢ | 37.0¢ | 34.5¢ | $2.959M | 8.301M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 74186 | 36.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
36.5¢ | 422090 | 8 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 74186 | 0.360 |
4 | 462590 | 0.355 |
12 | 1051622 | 0.350 |
14 | 497784 | 0.345 |
12 | 218070 | 0.340 |
Price($) | Vol. | No. |
---|---|---|
0.365 | 422090 | 8 |
0.370 | 527474 | 6 |
0.375 | 459885 | 7 |
0.380 | 245528 | 8 |
0.385 | 653019 | 10 |
Last trade - 16.10pm 15/10/2024 (20 minute delay) ? |
Featured News
BOT (ASX) Chart |
The Watchlist
JBY
JAMES BAY MINERALS LIMITED
Andrew Dornan, Executive Director
Andrew Dornan
Executive Director
SPONSORED BY The Market Online